Coronado Biosciences Inc Quick Ratio (CNDO) starting from the fourth quarter 2014 to fourth quarter , Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Coronado Biosciences Inc  (CNDO)

Coronado Biosciences Inc's Quick Ratio

CNDO's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Current Liabilities decreased faster than Coronado Biosciences Inc's Cash & cash equivalent, this led to improvement in Coronado Biosciences Inc's Quick Ratio to 17.11 a new company high.

Within Major Pharmaceutical Preparations industry 33 other companies have achieved higher Quick Ratio than Coronado Biosciences Inc in fourth quarter 2014. While Quick Ratio total ranking has improved so far during the Q4 2014 to 155, from total ranking in the fourth quarter 2013 at 179.

Explain Quick Ratio?
How much Cash & cash equivalents CNDO´s has?
What are CNDO´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CNDO Quick Ratio (Dec 31 2014)
Q4		 (Dec 31 2013)
Q4


Y / Y Current Liabilities Change - - - - -
Y / Y Cash & cash equivalent Change - - - - -
Quick Ratio MRQ 17.11 8.88 - - -
CNDO's Total Ranking # 155 # 179 # # #
Seq. Current Liabilities Change -63.63 % - - - -
Seq. Cash & cash equivalent Change -29.9 % - - - -



Quick Ratio fourth quarter 2014 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 34
Healthcare Sector # 52
Overall Market # 155


Quick Ratio Statistics
High Average Low
17.11 12.99 8.88
(Dec 31 2014)   (Dec 31 2013)




Financial Statements
Coronado Biosciences Inc's Current Liabilities $ 4 Millions Visit CNDO's Balance sheet
Coronado Biosciences Inc's Cash & cash equivalent $ 70 Millions Visit CNDO's Balance sheet
Source of CNDO's Sales Visit CNDO's Sales by Geography


Cumulative Coronado Biosciences Inc's Quick Ratio

CNDO's Quick Ratio for the trailling 12 Months

CNDO Quick Ratio

 (Dec 31 2014)
12 Months		 (Dec 31 2013)
12 Months
12 Months
12 Months
12 Months
Y / Y Current Liabilities TTM Growth - - - - -
Y / Y Cash & cash equivalent TTM Growth - - - - -
Quick Ratio TTM 11.07 8.88 - - -
Total Ranking TTM # 3239 # 0
Seq. Current Liabilities TTM Growth 36.37 % - - - -
Seq. Cash & cash equivalent TTM Growth 70.1 % - - - -

Quick ratio ranking by company, industry and sector >> Back to CNDO Financial Strength Comparisons >> Go to Compare CNDO Quick Ratio to its Competitors

On the trailing twelve months basis CNDO Cash & cash equivalent faded by -29.9 % in Q4 2014 year on year, faster than Current Liabilities, this led to increase in in Coronado Biosciences Inc's Quick Ratio to 11.07, above CNDO average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 157 other companies have achieved higher Quick Ratio than Coronado Biosciences Inc. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the fourth quarter 2013 from 0 to 3239.

Explain Quick Ratio?
How much Cash & cash equivalents CNDO´s has?
What are CNDO´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 158
Healthcare Sector # 393
Within the Market # 3239


trailing twelve months Quick Ratio Statistics
High Average Low
5.54 5.54 5.54
(Dec 31 2014)  




Companies with similar Quick Ratio in the quarter ending Dec 31 2014, within Major Pharmaceutical Preparations Industry Quick RatioDec 31 2014 MRQ Cash & cash equivalentDec 31 2014 MRQ Current Liabilities
Galmed Pharmaceuticals Ltd   46.47 $ 55.718  Millions$ 1.199  Millions
Clovis Oncology inc   45.90 $ 482.677  Millions$ 10.515  Millions
Evofem Biosciences Inc   39.77 $ 75.948  Millions$ 1.910  Millions
Esperion Therapeutics Inc   38.04 $ 105.841  Millions$ 2.782  Millions
Gyre Therapeutics Inc   36.85 $ 107.385  Millions$ 2.914  Millions
Tenax Therapeutics Inc   36.09 $ 58.321  Millions$ 1.616  Millions
Kindred Biosciences Inc   35.42 $ 101.027  Millions$ 2.852  Millions
Biospecifics Technologies Corp  30.86 $ 20.711  Millions$ 0.671  Millions
Nanoviricides inc   30.72 $ 37.697  Millions$ 1.227  Millions
Prothena Corporation Public Limited Company  30.10 $ 293.579  Millions$ 9.754  Millions
Sierra Oncology Inc   29.69 $ 67.011  Millions$ 2.257  Millions
Seres Therapeutics Inc   29.18 $ 114.185  Millions$ 3.913  Millions
Otonomy Inc   28.80 $ 156.033  Millions$ 5.417  Millions
China Yct International Group, Inc.  27.12 $ 24.195  Millions$ 0.892  Millions
Paratek Pharmaceuticals Inc   25.62 $ 95.856  Millions$ 3.741  Millions
Eledon Pharmaceuticals Inc   24.81 $ 105.256  Millions$ 4.243  Millions
Calithera Biosciences Inc   24.74 $ 101.969  Millions$ 4.121  Millions
Bio path Holdings inc   24.66 $ 13.859  Millions$ 0.562  Millions
Aravive Inc   24.63 $ 170.566  Millions$ 6.925  Millions
Trevena inc   24.40 $ 106.904  Millions$ 4.381  Millions
Marinus Pharmaceuticals Inc   24.38 $ 49.720  Millions$ 2.039  Millions
Lftd Partners Inc   23.52 $ 0.588  Millions$ 0.025  Millions
Iveric Bio Inc   23.38 $ 463.560  Millions$ 19.831  Millions
Teligent Inc   22.69 $ 158.883  Millions$ 7.002  Millions
Flexion Therapeutics Inc   22.30 $ 151.625  Millions$ 6.799  Millions
Oramed Pharmaceuticals Inc  21.90 $ 21.306  Millions$ 0.973  Millions
Oncotelic Therapeutics Inc   21.71 $ 30.031  Millions$ 1.383  Millions
Plx Pharma Inc   21.49 $ 27.090  Millions$ 1.261  Millions
Provectus Biopharmaceuticals Inc   20.52 $ 17.392  Millions$ 0.848  Millions
Oncosec Medical Incorporated  20.40 $ 30.699  Millions$ 1.505  Millions

Date modified: 2026-09-08T15:08:24+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.